State Offices of Women’s Health Support and Expansion Act

and dissemination to the public on women's health. ``(G) Conducting public educational forums or education initiatives in the State to-- ``(i) raise public awareness about women's health issues; and ``(ii) educate the public about women's health programs, issues, and services. ``(H) Coordinating with other entities that focus on women's health or women's issues on the activities and programs of the office on women's health and prioritizing outreach and coordination in rural and medically underserved areas. ``(3) Addressing social determinants of health by supporting initiatives that address housing instability, transportation barriers, food insecurity, workforce participation, access to childcare, and other non-clinical factors impacting health outcomes. ``(4) Establishing and convening, not less than annually, a community stakeholder advisory panel that will help in developing all strategic priorities, funding recommendations, and public awareness activities under this section. Stakeholders shall be sought through a fair and statewide call that is aligned with the goals and objectives of the State office of women's health and reflective of residents of the State. The panel shall consist of-- ``(A) representatives from community-based organizations that represent the most impacted communities, including those serving rural women, low- income women, and women of color; ``(B) women's health care providers, including obstetricians and gynecologists; ``(C) representatives from federally qualified health centers, health centers funded under title X, and rural health facilities; ``(D) representatives from nonprofit organizations with expertise related to the health of women; ``(E) individuals with expertise in public health research and education; ``(F) representatives from patient and consumer health advocacy organizations; ``(G) State Medicaid officials; ``(H) individuals from communities most impacted by reproductive health disparities, as determined appropriate by the State department of health; and ``(I) representatives from relevant State-based medical societies with expertise in the health of women. ``(d) Prohibited Uses of Funds.--A grant under this section may not be used, directly or indirectly (including through a subgrant), to-- ``(1) intentionally discourage or dissuade individuals from seeking or obtaining reproductive health services, including-- ``(A) abortion, including medication abortion; ``(B) contraceptive care; ``(C) assisted reproductive care; ``(D) hormone therapy; ``(E) sex education; and ``(F) testing for sexually transmitted infections; ``(2) withhold or misrepresent scientifically and medically accurate, evidence-based information regarding contraceptive methods, including over-the-counter contraceptives and prescription contraceptives (such as intrauterine devices and emergency contraception); ``(3) withhold, suppress, or misrepresent evidence-based clinical information regarding medication abortion, including the use of mifepristone and misoprostol; ``(4) withhold, suppress, or misrepresent medically accurate, evidence-based sex education information; ``(5) withhold, suppress, or misrepresent medically accurate, evidence-based public health information or information on women's health across the lifespan, including information on vaccines; or ``(6) restrict the ability of any person to seek or access any lawful health service. ``(e) Allocation of Funding.--Each fiscal year, the Secretary shall allocate funding under this section by distributing-- ``(1) 50 percent of such funding equally among all eligible States; and ``(2) 50 percent of such funding based on a formula accounting for female population, maternal mortality rates, poverty rates among women, and rural population proportion in each eligible State. ``(f) Privacy Protection.--Data collected by a State office of women's health established pursuant to this section may not-- ``(1) be used by, or in collaboration with, any digital website, application, or other platform that stores or processes personal data and information on servers external to those owned or controlled by the individuals serviced; ``(2) be used for any civil action, criminal prosecution, investigation, or other proceeding; or ``(3) be disclosed, sold, or shared with any digital website, application, or other platform in any way that identifies an individual or their health care provider. ``(g) Medicaid Data Sharing.-- ``(1) In general.--A State department of health may, in coordination with the State Medicaid agency, establish a data sharing agreement to facilitate the exchange of high-level, aggregate, de-identified data for the purpose of-- ``(A) identifying gaps in women's health services covered under the State Medicaid program; and ``(B) developing evidence-based proposals for Medicaid section 1115 demonstration waivers or State plan amendments that would improve women's health outcomes across the spectrum of care and throughout the lifespan. ``(2) Privacy protections.--Any data shared under this subsection shall be-- ``(A) de-identified in accordance with the standards described in section 164.514 of title 45, Code of Federal Regulations; ``(B) aggregated at a level that prevents the identification of any individual; and ``(C) used solely for the public health purposes described in this subsection. ``(h) Reporting.--A State receiving a grant under this section shall require the head of each State office of women's health being funded through the grant to annually submit to the Secretary a report-- ``(1) describing the priorities and services needed for women's health in the State; ``(2) identifying areas in need of improvement in women's health in the State; ``(3) summarizing the public education activities, community forums, and outreach efforts conducted during the preceding fiscal year; ``(4) describing the activities and findings of the community stakeholder advisory panel established under subsection (c)(4), if applicable; ``(5) that includes aggregate, anonymized data sufficient to support evidence-based policymaking and agency regulatory actions, but does not include any personally identifiable information, protected health information, or data that can be used to identify individual patients or providers or to subject individuals to criminal liability; and ``(6) identifying measurable improvements achieved and remaining gaps in access and outcomes, including disaggregated data by race, ethnicity, income level, and geography. ``(i) Authorization of Appropriations.--To carry out this section, there are authorized to be appropriated $55,000,000 for each of fiscal years 2027 through 2031.''. <all>